Bookmark

Add to MyYahoo RSS

Amarin News

News on Amarin (Ticker: AMRN) continually updated from thousands of sources around the net.

Tuesday Aug 12 | SchaeffersResearch.com

Amarin Corporation plc (AMRN) Call Buyers Eye Extended Gains

After all, the biopharmaceutical stock is off roughly 68% year-over-year, and short interest is on the rise.

Comment?

Related Topix: Biotech, Amarin, Medicine, Healthcare Industry, Day Trading, Financial Markets, Personal Finance

Mon Aug 11, 2014

Seeking Alpha

The FDA Gives Itself Room To Move On Amarin's Appeal

This is no ordinary review process based entirely upon scientific considerations, but rather an upper level deliberation based upon the legal implications of agency decision making thus far.

Comment?

Related Topix: Biotech, Marketing

Sun Aug 10, 2014

Seeking Alpha

Amarin Earnings - Company Making Progress

Amarin reported second quarter results on August 7, 2014 and the company has made considerable progress in a number of areas.

Comment?

Related Topix: Biotech

Fri Aug 08, 2014

Seeking Alpha

Amarin's (AMRN) CEO John Thero on Q2 2014 Results - Earnings Call Transcript

Greetings and welcome to the Amarin's Second Quarter 2014 Results Conference Call.

Comment?

Related Topix: Biotech, Marketing

Thu Aug 07, 2014

BayStreet.ca

Amarin to Host Second Quarter 2014 Earnings Conference Call and...

BEDMINSTER, NJ and DUBLIN, IRELAND / ACCESSWIRE / August 7, 2014 / Amarin Corporation plc will host a conference call and live webcast to discuss the results of the second quarter 2014, to be held Thursday, August 7, 2014 at 4:30 PM Eastern Time.

Comment?

Related Topix: Biotech, Amarin, Medicine, Healthcare Industry, Bedminster, NJ, Ireland, World News,

Tue Aug 05, 2014

Sys-Con Media

Amarin to Report Second Quarter 2014 Results and Host Conference Call on August 7, 2014

Amarin Corporation plc , a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to discuss the company's second quarter 2014 financial results and provide an operational update on ... (more)

Comment?

Related Topix: Biotech, Amarin, Medicine, Healthcare Industry

Mon Aug 04, 2014

Seeking Alpha

Amarin: Starting To Show Some Modest Vascepa Growth

Kowa representatives are not yet at full effectiveness given the suggested 5 to 6 month timeline for that to occur.

Comment?

Related Topix: Biotech

Thu Jul 31, 2014

TheStreet.com

Amarin Shocker: There's a Reason to be Bullish Right Now

This longtime Amarin bear believes there's now a compelling argument for going long the stock or its options -- if only for a speculative trade.

Comment?

Related Topix: Biotech

TheStreet.com

Amarin Shocker: There's a Reason to be Bullish Right Now

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Mozilla

Mon Jul 28, 2014

Seeking Alpha

MannKind: Let It Dip A Bit More, Then Cover/Buy

After briefly eclipsing the $11 mark, the stock has since pulled back to close the week at $8.77/share.

Comment?

Related Topix: Biotech, MannKind

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••